FRMD4B
geneOn this page
Also known as KIAA1013GRSP1
Summary
FRMD4B (FERM domain containing 4B, HGNC:24886) is a protein-coding gene on chromosome 3p14.1, encoding FERM domain-containing protein 4B (Q9Y2L6). Member of GRP1 signaling complexes that are acutely recruited to plasma membrane ruffles in response to insulin receptor signaling.
This gene encodes a GRP1-binding protein which contains a FERM protein interaction domain as well as two coiled coil domains. This protein may play a role as a scaffolding protein.
Source: NCBI Gene 23150 — RefSeq curated summary.
At a glance
- GWAS associations: 17
- Clinical variants (ClinVar): 184 total
- MANE Select transcript:
NM_015123
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24886 |
| Approved symbol | FRMD4B |
| Name | FERM domain containing 4B |
| Location | 3p14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1013, GRSP1 |
| Ensembl gene | ENSG00000114541 |
| Ensembl biotype | protein_coding |
| OMIM | 617467 |
| Entrez | 23150 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 10 protein_coding, 5 retained_intron, 4 protein_coding_CDS_not_defined
ENST00000398540, ENST00000459638, ENST00000460709, ENST00000462308, ENST00000462512, ENST00000462888, ENST00000470070, ENST00000473029, ENST00000473188, ENST00000478263, ENST00000483668, ENST00000487751, ENST00000489817, ENST00000493127, ENST00000493880, ENST00000497475, ENST00000497757, ENST00000497880, ENST00000863518
RefSeq mRNA: 1 — MANE Select: NM_015123
NM_015123
CCDS: CCDS46863
Canonical transcript exons
ENST00000398540 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001149203 | 69168782 | 69171981 |
| ENSE00001175437 | 69176524 | 69176656 |
| ENSE00001175443 | 69180899 | 69181710 |
| ENSE00001175454 | 69182598 | 69182717 |
| ENSE00001175465 | 69187770 | 69187917 |
| ENSE00001175474 | 69189896 | 69189952 |
| ENSE00001175482 | 69193648 | 69193873 |
| ENSE00001697213 | 69195022 | 69195141 |
| ENSE00001699364 | 69196255 | 69196396 |
| ENSE00001725123 | 69195231 | 69195364 |
| ENSE00001840385 | 69385828 | 69386088 |
| ENSE00003475493 | 69198698 | 69198774 |
| ENSE00003500809 | 69302343 | 69302435 |
| ENSE00003547599 | 69311263 | 69311357 |
| ENSE00003576743 | 69218322 | 69218379 |
| ENSE00003582902 | 69249226 | 69249248 |
| ENSE00003620920 | 69196900 | 69197038 |
| ENSE00003620942 | 69250043 | 69250099 |
| ENSE00003628002 | 69221858 | 69221923 |
| ENSE00003636720 | 69287752 | 69287836 |
| ENSE00003758870 | 69313452 | 69313517 |
| ENSE00003787893 | 69216263 | 69216349 |
| ENSE00003789462 | 69224607 | 69224690 |
Expression profiles
Bgee: expression breadth ubiquitous, 279 present calls, max score 97.08.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.6930 / max 475.2904, expressed in 1208 samples.
FANTOM5 promoters (28 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 42997 | 3.7712 | 563 |
| 42964 | 1.9312 | 362 |
| 42971 | 1.7103 | 426 |
| 42978 | 1.3299 | 218 |
| 42975 | 1.2851 | 377 |
| 42995 | 0.8621 | 292 |
| 42973 | 0.6595 | 257 |
| 42998 | 0.5418 | 231 |
| 42976 | 0.4592 | 224 |
| 42982 | 0.3188 | 126 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| germinal epithelium of ovary | UBERON:0001304 | 97.08 | gold quality |
| calcaneal tendon | UBERON:0003701 | 96.45 | gold quality |
| cortical plate | UBERON:0005343 | 96.38 | gold quality |
| sural nerve | UBERON:0015488 | 96.20 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 95.96 | gold quality |
| corpus callosum | UBERON:0002336 | 95.90 | gold quality |
| oral cavity | UBERON:0000167 | 94.97 | gold quality |
| ganglionic eminence | UBERON:0004023 | 94.66 | gold quality |
| squamous epithelium | UBERON:0006914 | 94.40 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 93.87 | gold quality |
| parietal pleura | UBERON:0002400 | 93.58 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 93.42 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 93.24 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 93.21 | gold quality |
| pleura | UBERON:0000977 | 92.63 | gold quality |
| gingival epithelium | UBERON:0001949 | 92.45 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.99 | gold quality |
| gingiva | UBERON:0001828 | 91.94 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 91.87 | gold quality |
| thyroid gland | UBERON:0002046 | 91.83 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 91.62 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 91.41 | gold quality |
| synovial joint | UBERON:0002217 | 91.27 | gold quality |
| parotid gland | UBERON:0001831 | 91.21 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 91.05 | gold quality |
| visceral pleura | UBERON:0002401 | 90.91 | gold quality |
| esophagus mucosa | UBERON:0002469 | 90.47 | gold quality |
| cranial nerve II | UBERON:0000941 | 90.31 | gold quality |
| monocyte | CL:0000576 | 90.16 | gold quality |
| right lung | UBERON:0002167 | 90.12 | gold quality |
Single-cell (SCXA)
Detected in 9 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-75367 | yes | 1796.26 |
| E-MTAB-11268 | yes | 1665.06 |
| E-HCAD-5 | yes | 302.77 |
| E-HCAD-35 | yes | 100.05 |
| E-HCAD-25 | yes | 62.56 |
| E-ANND-3 | yes | 18.43 |
| E-MTAB-6678 | yes | 10.53 |
| E-GEOD-137537 | yes | 4.00 |
| E-ANND-2 | no | 1002.32 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
219 targeting FRMD4B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-196A-5P | 100.00 | 68.16 | 684 |
| HSA-MIR-196B-5P | 100.00 | 68.16 | 681 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
Literature-anchored findings (GeneRIF, showing 2)
- SNP is located in a 3’ intronic region of the FRMD4B gene. FRMD4B as novel susceptibility loci for advanced heart failure. (PMID:20124441)
- association between the intronic rs6787362 FRMD4B SNP and ischemic cardiomyopathy in a European-derived population, but not FRMD4B variants as susceptibility factors in common heart failure (PMID:20718813)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | frmd4ba | ENSDARG00000074599 |
| danio_rerio | frmd4bb | ENSDARG00000076496 |
| mus_musculus | Frmd4b | ENSMUSG00000030064 |
| rattus_norvegicus | Frmd4b | ENSRNOG00000007764 |
| caenorhabditis_elegans | WBGENE00008555 |
Paralogs (6): EZR (ENSG00000092820), ERMN (ENSG00000136541), RDX (ENSG00000137710), MSN (ENSG00000147065), FRMD4A (ENSG00000151474), NF2 (ENSG00000186575)
Protein
Protein identifiers
FERM domain-containing protein 4B — Q9Y2L6 (reviewed: Q9Y2L6)
Alternative names: GRP1-binding protein GRSP1
All UniProt accessions (9): C9J6Q2, C9J7M5, C9JA15, C9JAW0, C9JBX2, C9JYK2, E9PGA7, Q9Y2L6, H7C550
UniProt curated annotations — full annotation on UniProt →
Function. Member of GRP1 signaling complexes that are acutely recruited to plasma membrane ruffles in response to insulin receptor signaling. May function as a scaffolding protein that regulates epithelial cell polarity by connecting ARF6 activation with the PAR3 complex. Plays a redundant role with FRMD4A in epithelial polarization.
Subunit / interactions. Interacts with CYTH3. Interacts with PARD3. Interacts with CYTH1.
Subcellular location. Cytoplasm. Cytoskeleton. Cell junction. Tight junction. Adherens junction.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y2L6-1 | 1 | yes |
| Q9Y2L6-2 | 2 |
RefSeq proteins (1): NP_055938* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000299 | FERM_domain | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR014352 | FERM/acyl-CoA-bd_prot_sf | Homologous_superfamily |
| IPR018979 | FERM_N | Domain |
| IPR018980 | FERM_PH-like_C | Domain |
| IPR019747 | FERM_CS | Conserved_site |
| IPR019748 | FERM_central | Domain |
| IPR019749 | Band_41_domain | Domain |
| IPR021774 | CUPID | Domain |
| IPR029071 | Ubiquitin-like_domsf | Homologous_superfamily |
| IPR035963 | FERM_2 | Homologous_superfamily |
| IPR041785 | FRMD4A/B_FERM_C | Domain |
| IPR047176 | FRMD4A/B | Family |
Pfam: PF00373, PF09379, PF09380, PF11819
UniProt features (28 total): compositionally biased region 8, region of interest 7, modified residue 4, coiled-coil region 2, cross-link 2, sequence conflict 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y2L6-F1 | 62.91 | 0.29 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (6): 372, 608, 697, 915, 882, 1029
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 325 (showing top):
YAGI_AML_WITH_INV_16_TRANSLOCATION, GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY, GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY, KAAB_HEART_ATRIUM_VS_VENTRICLE_UP, ASTON_MAJOR_DEPRESSIVE_DISORDER_DN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, GOCC_RUFFLE, BILD_SRC_ONCOGENIC_SIGNATURE, GOBP_ESTABLISHMENT_OF_CELL_POLARITY, MARTINEZ_RB1_TARGETS_UP, ONKEN_UVEAL_MELANOMA_UP, MARTIN_VIRAL_GPCR_SIGNALING_DN, TIEN_INTESTINE_PROBIOTICS_24HR_UP, BROWNE_HCMV_INFECTION_6HR_UP
GO Biological Process (1): establishment of epithelial cell polarity (GO:0090162)
GO Molecular Function (0):
GO Cellular Component (7): ruffle (GO:0001726), obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), adherens junction (GO:0005912), bicellular tight junction (GO:0005923), anchoring junction (GO:0070161)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| establishment of cell polarity | 1 |
| cell leading edge | 1 |
| plasma membrane bounded cell projection | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| cell-cell junction | 1 |
| apical junction complex | 1 |
| tight junction | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
870 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FRMD4B | CYTH3 | O43739 | 862 |
| FRMD4B | CYTH1 | Q15438 | 855 |
| FRMD4B | CYTH4 | Q9UIA0 | 629 |
| FRMD4B | CYTH2 | Q99418 | 616 |
| FRMD4B | HSPB7 | Q9UBY9 | 544 |
| FRMD4B | TMTC4 | Q5T4D3 | 519 |
| FRMD4B | GPA33 | Q99795 | 461 |
| FRMD4B | DYNLRB2 | Q8TF09 | 433 |
| FRMD4B | PLEKHA5 | Q9HAU0 | 425 |
| FRMD4B | NUSAP1 | Q9BXS6 | 418 |
| FRMD4B | CPNE4 | Q96A23 | 406 |
| FRMD4B | TMEM260 | Q9NX78 | 398 |
| FRMD4B | MEIG1 | Q5JSS6 | 383 |
| FRMD4B | CDKN2A | P42771 | 375 |
| FRMD4B | ARL4A | P40617 | 374 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FRMD4B | AFDN | psi-mi:“MI:0915”(physical association) | 0.400 |
| Xpo1 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| FRMD4B | Zap70 | psi-mi:“MI:0914”(association) | 0.350 |
| CYTH1 | CYTH3 | psi-mi:“MI:0914”(association) | 0.350 |
| NFIB | psi-mi:“MI:0914”(association) | 0.350 | |
| RSPH1 | FRMD4B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (11): FRMD4B (Affinity Capture-MS), RNF146 (Affinity Capture-Western), FRMD4B (Affinity Capture-Luminescence), FRMD4B (Proximity Label-MS), MLLT4 (Affinity Capture-MS), FRMD4B (Affinity Capture-MS), FRMD4B (Proximity Label-MS), FRMD4B (Two-hybrid), FRMD4B (Affinity Capture-MS), FRMD4B (Affinity Capture-MS), FRMD4B (Affinity Capture-RNA)
ESM2 similar proteins: A0A0G2K2P5, A0JNJ1, B1WAP7, G9CGD6, O14640, O75122, O88382, O95049, O97758, P34908, P39447, P51141, P54792, P70175, Q05AS8, Q07157, Q16825, Q5F488, Q5IS48, Q5SGD7, Q5TCQ9, Q5XI81, Q61062, Q62136, Q62728, Q62936, Q6DKE2, Q6P9H4, Q6ZM86, Q812E4, Q86UL8, Q8BMA3, Q8IVH8, Q8JHI3, Q8TDW5, Q920B0, Q924I2, Q925T6, Q92997, Q95168
Diamond homologs: A2AEV7, Q3KP66, Q7TN12, Q920B0, Q96HB5, Q9Y2L6, A2ALK8, B0WYY2, F1LYQ8, F1P065, F8VPU2, O35763, O43491, O70318, O94887, P11171, P12264, P15311, P26038, P26040, P26041, P26042, P26043, P26044, P26045, P29074, P31976, P31977, P35240, P35241, P46150, P46662, P48193, P52962, P59750, P86232, Q12923, Q170J7, Q24564, Q29GR8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
184 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 156 |
| Likely benign | 7 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3970 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:69176653:GACAC:G | acceptor_loss | 1.0000 |
| 3:69176654:ACACT:A | acceptor_loss | 1.0000 |
| 3:69176655:CA:C | acceptor_gain | 1.0000 |
| 3:69176656:ACTG:A | acceptor_loss | 1.0000 |
| 3:69176657:C:A | acceptor_loss | 1.0000 |
| 3:69176657:C:CC | acceptor_gain | 1.0000 |
| 3:69176658:T:A | acceptor_loss | 1.0000 |
| 3:69182594:TTA:T | donor_loss | 1.0000 |
| 3:69182595:TACT:T | donor_loss | 1.0000 |
| 3:69182596:A:AC | donor_gain | 1.0000 |
| 3:69182596:A:T | donor_loss | 1.0000 |
| 3:69182596:ACT:A | donor_gain | 1.0000 |
| 3:69182597:C:CC | donor_gain | 1.0000 |
| 3:69182597:CT:C | donor_gain | 1.0000 |
| 3:69182597:CTC:C | donor_gain | 1.0000 |
| 3:69182599:C:CA | donor_gain | 1.0000 |
| 3:69182713:TTTCT:T | acceptor_gain | 1.0000 |
| 3:69182714:TTCT:T | acceptor_gain | 1.0000 |
| 3:69182718:C:CC | acceptor_gain | 1.0000 |
| 3:69189894:A:AC | donor_gain | 1.0000 |
| 3:69189895:C:CC | donor_gain | 1.0000 |
| 3:69189895:CGAT:C | donor_gain | 1.0000 |
| 3:69189953:C:CC | acceptor_gain | 1.0000 |
| 3:69193646:A:T | donor_loss | 1.0000 |
| 3:69193647:C:T | donor_loss | 1.0000 |
| 3:69194977:T:TA | donor_gain | 1.0000 |
| 3:69195020:A:AC | donor_gain | 1.0000 |
| 3:69195021:C:CC | donor_gain | 1.0000 |
| 3:69195021:CTT:C | donor_gain | 1.0000 |
| 3:69195021:CTTCT:C | donor_gain | 1.0000 |
AlphaMissense
6771 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:69196943:G:T | A350E | 1.000 |
| 3:69196944:C:G | A350P | 1.000 |
| 3:69196953:A:G | W347R | 1.000 |
| 3:69196953:A:T | W347R | 1.000 |
| 3:69196986:A:G | W336R | 1.000 |
| 3:69196986:A:T | W336R | 1.000 |
| 3:69198719:A:T | V311D | 1.000 |
| 3:69198723:C:G | A310P | 1.000 |
| 3:69198724:A:C | F309L | 1.000 |
| 3:69198724:A:T | F309L | 1.000 |
| 3:69198725:A:C | F309C | 1.000 |
| 3:69198725:A:G | F309S | 1.000 |
| 3:69198726:A:G | F309L | 1.000 |
| 3:69198746:A:G | L302S | 1.000 |
| 3:69198755:A:G | L299P | 1.000 |
| 3:69198763:C:A | W296C | 1.000 |
| 3:69198763:C:G | W296C | 1.000 |
| 3:69198764:C:G | W296S | 1.000 |
| 3:69198765:A:G | W296R | 1.000 |
| 3:69198765:A:T | W296R | 1.000 |
| 3:69216307:C:G | G278R | 1.000 |
| 3:69216307:C:T | G278R | 1.000 |
| 3:69216321:C:T | G273E | 1.000 |
| 3:69216322:C:G | G273R | 1.000 |
| 3:69216322:C:T | G273R | 1.000 |
| 3:69216324:A:G | L272P | 1.000 |
| 3:69181054:A:G | L899S | 0.999 |
| 3:69195233:C:G | A456P | 0.999 |
| 3:69196924:A:C | F356L | 0.999 |
| 3:69196924:A:T | F356L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000007820 (3:69304711 T>G), RS1000008707 (3:69367413 C>T), RS1000020893 (3:69430986 C>A), RS1000026926 (3:69365567 C>T), RS1000040032 (3:69400167 C>G,T), RS1000040682 (3:69341725 G>A), RS1000045058 (3:69451176 T>A), RS1000049201 (3:69409297 T>A), RS1000049796 (3:69278590 G>C), RS1000055721 (3:69359031 C>T), RS1000084593 (3:69241957 G>A), RS1000089834 (3:69330897 G>A,T), RS1000094478 (3:69495929 A>C), RS1000115777 (3:69252398 C>T), RS1000117910 (3:69196021 C>G)
Disease associations
OMIM: gene MIM:617467 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
17 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000612_40 | Celiac disease | 2.000000e-07 |
| GCST003818_26 | Resting heart rate | 3.000000e-15 |
| GCST003902_1 | Fast beta electroencephalogram | 2.000000e-07 |
| GCST003944_38 | Hepcidin/ferritin ratio | 3.000000e-06 |
| GCST003944_39 | Hepcidin/ferritin ratio | 8.000000e-06 |
| GCST006138_40 | Resting-state electroencephalogram vigilance | 8.000000e-06 |
| GCST006414_78 | Atrial fibrillation | 3.000000e-09 |
| GCST007045_21 | PR interval | 6.000000e-09 |
| GCST008154_5 | Trunk fat mass | 3.000000e-07 |
| GCST008865_6 | Sphingomyelin 24:0 levels | 1.000000e-06 |
| GCST010064_2 | Celiac disease | 9.000000e-09 |
| GCST010151_10 | Carotid intima media thickness x smoking interaction | 7.000000e-06 |
| GCST010276_8 | Renal underexcretion gout | 1.000000e-07 |
| GCST010321_112 | PR interval | 1.000000e-19 |
| GCST010994_5 | High myopia | 2.000000e-08 |
| GCST011996_2 | dexamethasone sensitivity in B-cell precursor acute lymphoblastic leukaemia | 3.000000e-06 |
| GCST011997_2 | prednisolone sensitivity in B-cell precursor acute lymphoblastic leukaemia | 4.000000e-08 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004357 | electroencephalogram measurement |
| EFO:0007835 | alcohol dependence measurement |
| EFO:0007901 | hepcidin:ferritin ratio |
| EFO:0004462 | PR interval |
| EFO:0010118 | sphingomyelin measurement |
| EFO:0006527 | smoking status measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
37 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression | 3 |
| methylmercuric chloride | decreases expression | 2 |
| Air Pollutants | decreases expression, increases abundance | 2 |
| Smoke | decreases expression, increases abundance | 2 |
| aristolochic acid I | decreases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| sotorasib | affects cotreatment, decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | decreases expression | 1 |
| trichostatin A | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, decreases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| abrine | increases expression | 1 |
| trametinib | decreases expression, affects cotreatment | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Amphotericin B | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Lead | affects methylation | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Melphalan | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, increases expression | 1 |
| Tretinoin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): gout